TargetMol

ACEA1011

Product Code:
 
TAR-T23603
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T23603-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T23603-50mg50mg£1,661.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T23603-100mg100mg£2,079.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
ACEA1011 is a glycine site NMDA receptor antagonist. It may have analgesic effects.
CAS:
153504-72-4
Formula:
C9H4ClF3N2O2
Molecular Weight:
264.59
Purity:
0.98
SMILES:
FC(F)(F)c1cc(Cl)c2[nH]c(=O)c(=O)[nH]c2c1

References

1. Balster RL, Mansbach RS, Shelton KL, Nicholson KL, Grech DM, Wiley JL, Li H, Weber E. Behavioral pharmacology of two novel substituted quinoxalinedione glutamate antagonists. Behav Pharmacol. 1995 Aug;6(5 And 6):577-589. PubMed PMID: 11224365. 2. Woodward RM, Huettner JE, Tran M, Guastella J, Keana JF, Weber E. Pharmacology of 5-chloro-7-trifluoromethyl-1,4-dihydro-2,3-quinoxalinedione: a novel systemically active ionotropic glutamate receptor antagonist. J Pharmacol Exp Ther. 1995 Dec;275(3):1209-18. PubMed PMID: 8531083. 3. Lutfy K, Woodward RM, Keana JF, Weber E. Inhibition of clonic seizure-like excitatory effects induced by intrathecal morphine using two NMDA receptor antagonists: MK-801 and ACEA-1011. Eur J Pharmacol. 1994 Feb 11;252(3):261-6. PubMed PMID: 8162948. 4. Warner DS, Martin H, Ludwig P, McAllister A, Keana JF, Weber E. In vivo models of cerebral ischemia: effects of parenterally administered NMDA receptor glycine site antagonists. J Cereb Blood Flow Metab. 1995 Mar;15(2):188-96. PubMed PMID: 7860652.